In a patient receiving golimumab (for ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, or ulcerative colitis) who now has back pain possibly due to discitis, can short‑term oral prednisone be used for pain control while golimumab is postponed, and how would steroids affect a potential discitis?

Management of Back Pain and Discitis Risk During Golimumab Postponement

Direct Answer

Short-term oral prednisone (≤10 mg/day for <3 months) can provide symptomatic pain relief while golimumab is postponed, but it will not treat discitis and may worsen an active infection by suppressing immune responses and masking clinical signs of progression. 1

---

Pain Control Strategy During Golimumab Postponement

Corticosteroid Bridge Therapy

• Prednisone ≤10 mg/day can be used for rapid symptom control as a short-term bridge (less than 3 months) while golimumab is held. 1
• The dose should be the lowest effective amount and tapered as soon as the clinical situation permits. 1, 2
• Prolonged corticosteroid use beyond 1–2 years is associated with cumulative toxicity including osteoporosis, fractures, cataracts, and cardiovascular disease. 1, 2

Alternative Pain Management Options

• NSAIDs (e.g., meloxicam 7.5–15 mg daily) are first-line for mechanical back pain associated with spinal stenosis or degenerative disease. 3
• Before prescribing NSAIDs, assess cardiovascular and gastrointestinal risk factors; consider co-administration with a proton-pump inhibitor in higher-risk patients. 3
• For radicular pain due to herniated disk, a 15-day tapering course of oral prednisone (60 mg × 5 days, 40 mg × 5 days, 20 mg × 5 days) modestly improves function at 3 weeks but does not significantly reduce pain. 4

---

Impact of Corticosteroids on Discitis

Infection Risk and Masking of Symptoms

• Systemic corticosteroids suppress immune responses and can mask fever, elevate white blood cell counts, and obscure clinical signs of infection progression, making discitis harder to diagnose and monitor. 1
• Long-duration corticosteroid therapy (>30 days) without additional immunosuppression is associated with increased infection rates compared with short-duration steroid plus targeted immunosuppressive therapy. 1
• If discitis is confirmed or strongly suspected, corticosteroids should be avoided or used only under close infectious disease consultation with concurrent antimicrobial therapy.

Diagnostic Workup for Discitis

• Obtain MRI of the spine with and without contrast to evaluate for discitis/osteomyelitis if back pain is accompanied by fever, elevated inflammatory markers (ESR, CRP), or neurologic deficits. (General medical knowledge)
• Blood cultures, ESR, and CRP should be obtained before initiating empiric antibiotics if infection is suspected. (General medical knowledge)
• If MRI confirms discitis, golimumab must remain postponed until the infection is fully treated, typically requiring 6–12 weeks of intravenous antibiotics. (General medical knowledge)

---

When to Resume Golimumab

Infection Clearance Criteria

• Golimumab should not be resumed until discitis is excluded or, if present, fully treated with normalization of inflammatory markers and clinical resolution. 1
• Repeat MRI and consultation with infectious disease specialists are recommended before restarting TNF inhibitors after treated discitis. (General medical knowledge)

Alternative Biologic Considerations

• If golimumab must be held long-term and inflammatory arthritis control is inadequate, consider switching to an alternative TNF inhibitor (infliximab, adalimumab) or a non-TNF biologic (vedolizumab for ulcerative colitis, abatacept or rituximab for rheumatoid arthritis) after infection resolution. 1, 2

---

Critical Pitfalls to Avoid

• Do not use corticosteroids as sole therapy for inflammatory arthritis; they provide only symptomatic relief without disease modification and permit unchecked joint damage. 1, 2
• Do not continue prednisone beyond 3 months without escalating to steroid-sparing DMARDs or biologics, as prolonged use increases infection risk and other toxicities. 1
• Do not restart golimumab without excluding active infection; TNF inhibitors markedly increase the risk of serious infections including vertebral osteomyelitis. 1
• Do not rely on prednisone to treat discitis; it requires targeted antimicrobial therapy and may worsen outcomes if infection is present. 1

---

Algorithmic Approach

1. Confirm or exclude discitis: Obtain MRI spine with contrast, blood cultures, ESR, CRP.
2. If discitis is confirmed: Hold golimumab indefinitely, initiate IV antibiotics, avoid corticosteroids unless absolutely necessary under infectious disease guidance.
3. If discitis is excluded and pain is mechanical: Use NSAIDs (meloxicam 7.5–15 mg daily) as first-line; add prednisone ≤10 mg/day for <3 months only if NSAIDs are insufficient. 3, 1
4. If discitis is excluded and pain is inflammatory (axial spondyloarthritis flare): Use prednisone ≤10 mg/day as a bridge while arranging alternative biologic therapy or resuming golimumab once safe. 1, 2
5. Monitor closely: Reassess pain, inflammatory markers, and infection signs every 1–2 weeks while golimumab is held. 1
6. Resume golimumab: Only after infection is excluded or fully treated, inflammatory markers normalize, and clinical resolution is confirmed. 1